top of page



High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP
I. de Souza, L. K. S. Monteiro, C. B. Guedes, M. M. Silva, M. Andrade-Tomaz, B. Contieri, M. T. Latancia, D. Mendes, B. F. M. M. Porchia,...
Clarissa Rocha
8 de jul. de 20222 min de leitura
Â
Â
Â


Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment
Izadora de Souza, Maria Carolina Clares Ramalho, Camila Banca Guedes, Isabeli Yumi Araújo Osawa, Linda Karolynne Seregni Monteiro,...
Clarissa Rocha
21 de jun. de 20221 min de leitura
Â
Â
Â


Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries
Clarissa Ribeiro Reily Rocha, Alexandre Reily Rocha, Matheus Molina Silva, Luciana Rodrigues Gomes, Marcela Latância, Marina Andrade Tomaz,
Clarissa Rocha
1 de dez. de 20201 min de leitura
Â
Â
Â


DNA repair pathways and cisplatin resistance: an intimate relationship
Clarissa Ribeiro Reily Rocha, Matheus Molina Silva, Annabel Quinet, Januario Bispo Cabral-Neto, Carlos Frederico Martins Menck, Clinics, 201
Clarissa Rocha
20 de abr. de 20181 min de leitura
Â
Â
Â


NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
Clarissa Ribeiro Reily Rocha, Gustavo Satoru Kajitani, Annabel Quinet, Rodrigo Soares Fortunato, and Carlos Frederico Martins Menck,...
Clarissa Rocha
17 de jun. de 20161 min de leitura
Â
Â
Â


Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in
CRR Rocha , CCM Garcia, DB Vieira , A Quinet , LC de Andrade-Lima , V Munford , JE Belizário and CFM Menck
Clarissa Rocha
30 de out. de 20142 min de leitura
Â
Â
Â


The role of DNA repair in the pluripotency and differentiation of human stem cells
Clarissa Ribeiro Reily Rocha, Leticia Koch Lerner, Oswaldo Keith Okamoto, Maria Carolina Marchetto, Carlos Frederico Martins Menck
Clarissa Rocha
23 de set. de 20122 min de leitura
Â
Â
Â
bottom of page